The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage.
Cerebral amyloid angiopathy (CAA) is associated with apolipoprotein E (APOE gene, apoE protein) polymorphism: current evidence suggests that the epsilon4 allele is a risk factor for the development of CAA and the epsilon2 allele predisposes to hemorrhage. We sought to determine the relationship between the APOE epsilon2 allele and both the immunoreactivity profiles and vascular complications of CAA. We performed immunohistochemistry for amyloid beta-protein (A beta), apoE, cystatin C, and activated microglia, and examined the morphology of cortical and leptomeningeal vessels in 37 CAA-related hemorrhage (CAAH), 26 Alzheimer disease (AD) patients, and 20 controls. The extent of immunostaining of vessels for A beta, apoE, cystatin C, and perivascular activated microglia increased from controls through AD to a maximum in CAAH patients. Among cases with CAA (37 CAAH, 19 AD, and 6 controls, n = 62) vascular apoE (p < 5 x 10(-4)), cystatin C (p < 10(-4)), activated microglia (p < 10(-4)), vessels with a high ratio of wall thickness to lumen diameter (p < 0.003) as well as dilated/microaneurysmal vessels (p < 0.01) were present more frequently in patients with hemorrhage than without; however, these features were not associated with the APOE epsilon2 allele. Fibrinoid necrosis alone was associated with the APOE epsilon2 allele (p < 0.04) and we suggest that over-representation of APOE epsilon2 in CAAH may result from its association with fibrinoid necrosis.
McCarron
M O
MO
Department of Neuropathology, Institute of Neurological Sciences, Southern General Hospital, Glasgow, United Kingdom.
Nicoll
J A
JA
Stewart
J
J
Ironside
J W
JW
Mann
D M
DM
Love
S
S
Graham
D I
DI
Dewar
D
D
D000368:Aged; D000483:Alleles; D000544:Alzheimer Disease / Q000378:metabolism / Q000473:pathology; D016229:Amyloid beta-Peptides / Q000378:metabolism; D053329:Apolipoprotein E2; D001057:Apolipoproteins E / Q000235:genetics* / Q000378:metabolism; D016657:Cerebral Amyloid Angiopathy / Q000150:complications* / Q000235:genetics* / Q000378:metabolism; D002543:Cerebral Hemorrhage / Q000209:etiology* / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D002532:Intracranial Aneurysm / Q000209:etiology / Q000473:pathology; D008297:Male; D009336:Necrosis; D012016:Reference Values
D016229:Amyloid beta-Peptides; D053329:Apolipoprotein E2; D001057:Apolipoproteins E